Previous Article | Next Article 
Journal of Clinical Microbiology, October 2002, p. 3789-3792, Vol. 40, No. 10
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.10.3789-3792.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Mutations in the rpoB and katG Genes Leading to Drug Resistance in Mycobacterium tuberculosis in Latvia
T. Tracevska,1* I. Jansone,1 L. Broka,2 O. Marga,3 and V. Baumanis1
Laboratory of Molecular Microbiology, Biomedical Research and Study Centre, University of Latvia,1
Latvian State Center for Tuberculosis and Lung Diseases, District of Riga,2
Latvian Academy of Medicine, Riga, Latvia3
Received 29 March 2002/
Returned for modification 21 June 2002/
Accepted 12 July 2002
To characterize the genetic basis of drug resistance in Mycobacterium tuberculosis in Latvia, mutations involved in rifampin (rpoB gene) and isoniazid (katG gene) resistance in DNA from 19 drug-susceptible and 51 multidrug-resistant M. tuberculosis complex isolates were analyzed. The most frequent rpoB gene mutations found by the Line Probe assay were the S531L (14 of 34 isolates), D516V (7 of 34), H526D (4 of 34), and D516Y plus P535S (4 of 34) mutations. Direct sequencing of seven isolates with unclear results from Line Probe assay showed the presence of the L533P mutation and the Q510H plus H526Y (1 of 34) and D516V plus P535S (4 of 34) double mutations, neither of which has been described previously. Single-strand conformation polymorphism analysis showed strand mobility differences between the rifampin-susceptible and -resistant samples for the D516V, H526D, and D516Y plus P535S mutations but not for the S531L mutation. Nucleotide substitution at codon 315 (AGC
ACC) of the katG gene was found in 48 of 51 multidrug-resistant samples by sequencing. Furthermore, katG gene restriction fragment length polymorphism analysis with endonuclease AciI confirmed the nucleotide change in codon 315.
* Corresponding author. Mailing address: Laboratory of Molecular Microbiology, Biomedical Research and Study Centre, University of Latvia, Ratsupites 1, Riga, LV-1067 Latvia. Phone: 371-7808218. Fax: 371-7442407. Email:
tatjanap{at}biomed.lu.lv.
Journal of Clinical Microbiology, October 2002, p. 3789-3792, Vol. 40, No. 10
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.10.3789-3792.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Abe, C., Kobayashi, I., Mitarai, S., Wada, M., Kawabe, Y., Takashima, T., Suzuki, K., Sng, L.-H., Wang, S., Htay, H. H., Ogata, H.
(2008). Biological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in Japan. J. Clin. Microbiol.
46: 2263-2268
[Abstract]
[Full Text]
-
Soudani, A., Hadjfredj, S., Zribi, M., Masmoudi, A., Messaoud, T., Tiouri, H., Fendri, C.
(2007). Characterization of Tunisian Mycobacterium tuberculosis Rifampin-Resistant Clinical Isolates. J. Clin. Microbiol.
45: 3095-3097
[Abstract]
[Full Text]
-
Jureen, P., Engstrand, L., Eriksson, S., Alderborn, A., Krabbe, M., Hoffner, S. E.
(2006). Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis by Pyrosequencing Technology.. J. Clin. Microbiol.
44: 1925-1929
[Abstract]
[Full Text]
-
O'Sullivan, D. M., McHugh, T. D., Gillespie, S. H.
(2005). Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?. J Antimicrob Chemother
55: 674-679
[Abstract]
[Full Text]
-
Baker, L. V., Brown, T. J., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., Drobniewski, F. A.
(2005). Molecular Analysis of Isoniazid-Resistant Mycobacterium tuberculosis Isolates from England and Wales Reveals the Phylogenetic Significance of the ahpC -46A Polymorphism. Antimicrob. Agents Chemother.
49: 1455-1464
[Abstract]
[Full Text]
-
Hillemann, D., Kubica, T., Rusch-Gerdes, S., Niemann, S.
(2005). Disequilibrium in Distribution of Resistance Mutations among Mycobacterium tuberculosis Beijing and Non-Beijing Strains Isolated from Patients in Germany. Antimicrob. Agents Chemother.
49: 1229-1231
[Abstract]
[Full Text]
-
Jou, R., Chen, H.-Y., Chiang, C.-Y., Yu, M.-C., Su, I.-J.
(2005). Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates and Identification of 11 Novel rpoB Alleles in Taiwan. J. Clin. Microbiol.
43: 1390-1394
[Abstract]
[Full Text]
-
Herrera-Leon, L., Molina, T., Saiz, P., Saez-Nieto, J. A., Jimenez, M. S.
(2005). New Multiplex PCR for Rapid Detection of Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates. Antimicrob. Agents Chemother.
49: 144-147
[Abstract]
[Full Text]
-
Tracevska, T., Jansone, I., Baumanis, V., Nodieva, A., Marga, O., Skenders, G.
(2004). Spectrum of pncA Mutations in Multidrug-Resistant Mycobacterium tuberculosis Isolates Obtained in Latvia. Antimicrob. Agents Chemother.
48: 3209-3210
[Full Text]
-
Sajduda, A., Brzostek, A., Poplawska, M., Augustynowicz-Kopec, E., Zwolska, Z., Niemann, S., Dziadek, J., Hillemann, D.
(2004). Molecular Characterization of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis Strains Isolated in Poland. J. Clin. Microbiol.
42: 2425-2431
[Abstract]
[Full Text]